Zobrazeno 1 - 10
of 230
pro vyhledávání: '"Bp, Chen"'
Publikováno v:
European Cells & Materials, Vol 26, Pp 195-207 (2013)
The functional repair of large skeletal defects remains a significant challenge to orthopaedic surgeons due to the lack of effective strategies to promote bone regeneration, particularly in the elderly. This study investigated the potential use of bo
Externí odkaz:
https://doaj.org/article/e301238c6e3145f6baacb89a95c96e13
Publikováno v:
Value in Health. 19:A175-A176
Publikováno v:
Blood. 86:183-192
Intravenous injection of dichloromethylene diphosphonate (Cl2MDP) encapsulated in liposomes results in specific elimination of macrophages in the spleen and liver of normal mice. Severe combined immunodeficient (SCID) mice were treated with Cl2MDP-li
Publikováno v:
Europe PubMed Central
The present study compared the T-cell progenitor content of CD34+ lineage (Lin)- cells isolated from normal adult bone marrow (ABM) and mobilized peripheral blood (MPB). Both cell populations were found to differentiate into T cells when injected int
Autor:
Bp, Chen, Mg, Rumi, Colombo M, Yh, Lin, Ramaswamy L, Luna J, Jk, Liu, Daniele Prati, Pm, Mannucci
Publikováno v:
Europe PubMed Central
The prevalence of the blood-borne TT virus (TTV) in Italian hemophiliacs treated with different preparations of factor VIII was determined. Of the 178 hemophilic patients (mean age, 29 years), TTV-DNA was found in 123 (69%), in comparison to 22 of 10
Autor:
Urashima M, Bp, Chen, Chen S, Gs, Pinkus, Rt, Bronson, Da, Dedera, Hoshi Y, Teoh G, Atsushi Ogata, Sp, Treon, Chauhan D, Kc, Anderson
Publikováno v:
Europe PubMed Central
Prior in vitro studies have suggested a role of adhesion molecules, bone marrow stromal cells (BMSCs), and cytokines in the regulation of human multiple myeloma (MM) cell growth and survival. Although in vivo models have been developed in severe comb
Autor:
P Fisch, G Weil-Hillman, M Uppenkamp, JA Hank, BP Chen, JA Sosman, A Bridges, OR Colamonici, PM Sondel
Publikováno v:
Blood. 74:343-353
Culturing of leukemic blood lymphocytes from a patient with acute T- cell lymphoblastic leukemia (T-ALL) with interleukin-2 (IL-2) yielded T- cell line AK-1 with a remarkable cytotoxic specificity. This line mediated strong lysis of tumor target line
Autor:
Bp, Chen, Fraser C, Reading C, Murray L, Uchida N, Anne GALY, Sasaki D, Tricot G, Jagannath S, Barlogie B
Publikováno v:
Europe PubMed Central
Gene-therapy of blood-borne disorders may be best achieved using hematopoietic stem cells (HSC) which have extensive self renewal potential as well as multilineage repopulating potential as a cellular target. The human HSC, which is CD34+Thy-1+Lin- h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::96b736633e92bdd43ed2b3834faa5df0
http://europepmc.org/abstract/med/7475307
http://europepmc.org/abstract/med/7475307
Autor:
Flener JL; Proliance Orthopedic Associates, Renton, WA, USA., Chen BP; Health Economics and Market Access, Ethicon Inc., Raritan, NJ, USA., Ernst FR; Real World Evidence and Late Phase, CTI Clinical Trial and Consulting Services, Covington, KY, USA., Libolt A; Proliance Orthopedic Associates, Renton, WA, USA., Gunja NJ; Health Economics and Market Access, Ethicon Inc., Raritan, NJ, USA., Barrett WP; Proliance Orthopedic Associates, Renton, WA, USA.
Publikováno v:
Pragmatic and observational research [Pragmat Obs Res] 2024 Jul 19; Vol. 15, pp. 93-102. Date of Electronic Publication: 2024 Jul 19 (Print Publication: 2024).
Autor:
Tan Z; Health Economics & Market Access, Ethicon Inc., Raritan, NJ, USA., Tomaszewski J; Medical Affairs, Ethicon Inc., Raritan, NJ, USA., Chen BP; Health Economics & Market Access, Ethicon Inc., Raritan, NJ, USA., Gunja NJ; Health Economics & Market Access, Ethicon Inc., Raritan, NJ, USA., Etter K; Health Economics & Market Access, Ethicon Inc., Raritan, NJ, USA.
Publikováno v:
Journal of comparative effectiveness research [J Comp Eff Res] 2024 Apr; Vol. 13 (4), pp. e230110. Date of Electronic Publication: 2024 Feb 28.